Stay updated with breaking news from Adding Advanced. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DUBLIN, Jan. 19, 2022 The "Sepsis Diagnostics - Global Markets by Assay, by Cause, by Product, by Lab, and by Place, with Executive and Consultant Guides and...
5.3.3 Diagnostics Moves Out of the Lab 5.3.4 Biomarkers and Algorithms 5.3.6 Genome Role and Big Data 5.3.7 The Next Five Years 6 Sepsis Diagnostics - Recent Developments 6.1 Recent Developments - Importance and How to Use This Section 6.1.1 Importance of These Developments 6.1.2 How to Use This Section 6.2 Study Establishes Cytovale IntelliSep Test for Rapid Diagnosis of Sepsis 6.3 Baebies Awarded $11.6M to Develop Diagnostic Platform to ID Sepsis 6.4 Personalized Medicine in Sepsis 6.5 Point-of-care Device can Diagnose Sepsis in 30 Minutes 6.6 SpeeDx Developing Respiratory Virus Host-Respon...
Share this article Share this article ResearchAndMarkets.com's offering. Sepsis was killing over 30 million people a year with no definitive diagnostic in hand. And now the COVID-19 Pandemic has increased the sepsis death toll. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life-saving diagnostics can command a premium in the market, especially deaths related to COVID-19 infections. Understand the different drivers of this huge global diagn...